1
Study of the Combination of DKN-01 and Nivolumab in Previously Treated Patients With Advanced Biliary Tract Cancer (BTC)
Condition(s):Biliary Tract CancerLast Updated:January 26, 2021Recruiting
Biliary Tract Cancer: 425 Clinical Trials, Page 1 of 43
Hide Studies Not Open or Pending
2
A Phase Ib/II Clinical Study of Camrelizumab and Apatinib Plus GP in the Treatment of Advanced Biliary Tract Cancer
Condition(s):Locally Advanced Biliary Tract Cancer; Metastatic Biliary Tract CancerLast Updated:February 24, 2023Not yet recruiting
3
Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer
Condition(s):Biliary Tract CancerLast Updated:September 27, 2022Recruiting
4
Allogeneic NK Cell (“SMT-NK”) in Combination With Pembrolizumab in Advanced Biliary Tract Cancer
Condition(s):Biliary Tract CancerLast Updated:March 29, 2022Completed
5
A Study of the Efficacy and Safety of Chemotherapy Combined With Toripalimab in Advanced Biliary Tract Cancer
Condition(s):Biliary Tract CancerLast Updated:January 8, 2019Recruiting
6
Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers
Condition(s):Biliary Tract CancerLast Updated:May 9, 2017Unknown status
7
Lenvatinib Plus Paclitaxel for Patients With Advanced Biliary Tract Cancer Who Failed to Gemcitabine-based Treatment
Condition(s):Advanced Biliary Tract CancerLast Updated:July 29, 2022Recruiting
8
Molecular Profiling of Advanced Biliary Tract Cancers
Condition(s):Biliary Tract CancerLast Updated:November 4, 2022Recruiting
9
The Registry of Genetic Alterations of Taiwan Biliary Tract Cancer
Condition(s):Biliary Tract Cancer (BTC)Last Updated:February 8, 2023Recruiting
10
NGS as the First-line Treatment in Advanced Biliary Tract Cancer
Condition(s):Advanced Biliary Tract CancerLast Updated:February 8, 2023Active, not recruiting